LEXICON PHARMACEUTICALS INC's ticker is LXRX and the CUSIP is 528872302. A total of 104 filers reported holding LEXICON PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.62 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $21,794,912 | -52.4% | 19,995,332 | 0.0% | 0.59% | -53.9% |
| Q2 2023 | $45,789,310 | +16.7% | 19,995,332 | +23.8% | 1.28% | -11.1% |
| Q1 2023 | $39,242,505 | +27.2% | 16,149,179 | 0.0% | 1.44% | +10.2% |
| Q4 2022 | $30,844,932 | -20.4% | 16,149,179 | 0.0% | 1.30% | -18.7% |
| Q3 2022 | $38,758,000 | +47.3% | 16,149,179 | +14.1% | 1.60% | +26.0% |
| Q2 2022 | $26,317,000 | -12.3% | 14,149,179 | -1.4% | 1.27% | +5.9% |
| Q1 2022 | $30,005,000 | -47.0% | 14,356,589 | -0.0% | 1.20% | -41.6% |
| Q4 2021 | $56,578,000 | -18.1% | 14,360,000 | 0.0% | 2.05% | -23.8% |
| Q3 2021 | $69,072,000 | +79.3% | 14,360,000 | +71.1% | 2.70% | +86.6% |
| Q2 2021 | $38,528,000 | -21.8% | 8,394,000 | 0.0% | 1.44% | -21.8% |
| Q1 2021 | $49,273,000 | +31.4% | 8,394,000 | -23.4% | 1.85% | +25.2% |
| Q4 2020 | $37,493,000 | – | 10,963,000 | – | 1.48% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ulys, L.L.C. | 4,321,214 | $25,366,000 | 100.00% |
| Artal Group S.A. | 71,178,364 | $417,817,000 | 7.38% |
| BVF INC/IL | 8,394,000 | $49,273,000 | 1.85% |
| Boothe Investment Group, Inc. | 435,939 | $2,559,000 | 1.49% |
| Campbell & CO Investment Adviser LLC | 103,100 | $605,000 | 0.37% |
| NEA Management Company, LLC | 2,382,286 | $13,984,000 | 0.31% |
| PINNACLE ASSOCIATES LTD | 2,167,172 | $12,721,000 | 0.24% |
| Eversept Partners, LP | 410,593 | $2,410,181 | 0.18% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 35,714 | $210,000 | 0.12% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 66,299 | $389,000 | 0.08% |